Inozyme Pharma, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Inozyme Pharma, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2020 to Q1 2025.
  • Inozyme Pharma, Inc. Operating Lease, Liability, Current for the quarter ending March 31, 2025 was $669K, a 28.4% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $669K -$265K -28.4% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $913K +$3K +0.33% Dec 31, 2024 10-Q 2025-05-14
Q3 2024 $985K +$99K +11.2% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $959K +$97K +11.3% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $934K +$95K +11.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $910K +$94K +11.5% Dec 31, 2023 10-K 2025-03-10
Q3 2023 $886K +$92K +11.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $862K +$89K +11.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $839K +$87K +11.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $816K +$85K +11.6% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $794K +$83K +11.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $773K +$82K +11.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $752K +$80K +11.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $731K +$731K Dec 31, 2021 10-K 2023-03-22
Q3 2021 $711K Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $691K Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $672K Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.